Operating
Change in fair value of equity securities
Biogen Change in fair value of equity securities increased by 3900.0% to $19.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 146.5%, from -$40.90M to $19.00M.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ3 2018
Last reportedQ1 2026Apr 29, 2026
Metric ID:
intc_equity_securities_fvni_changeHistorical Data
15 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$426.90M | -$116.30M | -$191.10M | -$78.20M | -$105.60M | -$79.60M | $106.40M | -$302.50M | -$1.40M | -$31.30M | -$30.30M | -$78.70M | -$40.90M | -$500.00K | $19.00M |
| QoQ Change | — | +72.8% | -64.3% | +59.1% | -35.0% | +24.6% | +233.7% | -384.3% | +99.5% | <-999% | +3.2% | -159.7% | +48.0% | +98.8% | >999% |
| YoY Change | — | — | — | — | +9.2% | +58.3% | +236.1% | — | +98.7% | +60.7% | -128.5% | <-999% | -30.7% | — | +146.5% |
Range-$426.90M – $106.40M
CAGR-58.9%
Avg YoY Growth-563.5%
Median YoY Growth+58.3%
Current Streak3 quarters growth
Change in fair value of equity securities at Other Companies
Frequently Asked Questions
- What is Biogen's change in fair value of equity securities?
- Biogen (BIIB) reported change in fair value of equity securities of $19.00M in Q1 2026.
- How has Biogen's change in fair value of equity securities changed year-over-year?
- Biogen's change in fair value of equity securities increased by 146.5% year-over-year, from -$40.90M to $19.00M.